Jay Boyle
Physician · Memorial Sloan Kettering Cancer Center
Credentials: · · ·
History
- 2019–Present
Research
Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck
New England Journal of Medicine · 1995 · 618 citations
Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck
Cancer Research · 1999 · 603 citations
The incidence of p53 mutations increases with progression of head and neck cancer
Cancer Research · 1993 · First of 10 authors · 573 citations
40 papers
38 papers
35 papers
- SP
35 papers
30 papers
25 papers
- NL
Nancy Lee
25 papers
- DK
22 papers
Grants
- 2004–2008
Planning a Trial of Sulindac for Oral Leukoplakia
National Institute of Dental and Craniofacial Research · R21
Contact PI · $290K · Sloan-Kettering Inst Can Research
- 2005–2008
Phase II Study of Sulindac in Oral Premalignant Lesions
National Cancer Institute · R03
Contact PI · $130.3K · Sloan-Kettering Inst Can Research
Clinical trials
- 2006
Rosiglitazone Maleate in Treating Patients With Oral Leukoplakia
Principal investigator · Completed · Phase 2
National Cancer Institute (NCI)
- 2006–2020
A Randomized Study of Sulindac in Oral Premalignant Lesions
Principal investigator · Completed
Memorial Sloan Kettering Cancer Center
- 2005–2015
Biomarkers of Molecular Risk in Smokers
Principal investigator · Completed
Memorial Sloan Kettering Cancer Center
- 2003–2010
Molecular Effects of Short-Term Celecoxib Treatment on Head and Neck Squamous Cell Carcinoma
Principal investigator · Completed
Memorial Sloan Kettering Cancer Center